|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.49 USD | -1.19% |
|
-4.99% | -1.94% |
| 07-07 | RBC Capital Adjusts PTC Therapeutics Price Target to $85 From $82, Maintains Sector Perform Rating | MT |
| 06-29 | PTC Therapeutics, Inc.(NasdaqGS:PTCT) added to Russell 2000 Value-Defensive Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.19% | -4.99% | -8.68% | +15.40% | -1.94% | +51.13% | +81.99% | +94.80% | +1,147.74% | 6.18B | |
| -0.87% | +4.04% | -1.62% | +42.15% | +12.59% | +58.60% | +163.92% | +393.22% | +1,359.79% | 1,079B | |
| -0.45% | +3.87% | +2.72% | +16.79% | +28.31% | +57.95% | +52.18% | +54.22% | +112.03% | 640B | |
| +0.04% | +3.95% | +3.54% | +29.14% | +15.23% | +37.69% | +74.54% | +121.50% | +297.55% | 465B | |
| -0.48% | +2.66% | +7.81% | +12.69% | +9.32% | +38.21% | +32.59% | +2.41% | +46.21% | 353B | |
| -0.30% | +1.10% | +1.96% | +11.35% | +17.76% | +35.82% | +41.72% | +53.86% | +62.03% | 301B | |
| -0.82% | +2.54% | -7.73% | -6.72% | -5.66% | +13.15% | +16.31% | +57.35% | +156.81% | 271B | |
| -0.41% | +4.98% | +6.88% | +23.51% | +3.38% | +3.46% | -38.43% | +15.95% | +76.56% | 228B | |
| -1.39% | +5.90% | +7.51% | +14.68% | +18.43% | +27.70% | +64.00% | +59.88% | +125.33% | 209B | |
| -1.18% | +1.83% | +5.07% | +3.02% | +8.14% | +16.20% | +72.69% | +90.08% | +67.02% | 165B | |
| -0.40% | +1.33% | +3.20% | -4.23% | +1.00% | +3.50% | -30.27% | -41.22% | -31.82% | 143B | |
| -0.79% | +3.85% | +7.75% | +9.57% | +16.98% | +34.66% | +2.75% | -7.41% | -15.65% | 129B | |
| -1.44% | +2.28% | -3.27% | +14.20% | +6.61% | +3.19% | +36.51% | +141.21% | +398.28% | 123B | |
| -1.99% | +2.80% | +4.56% | -1.65% | -5.10% | -8.21% | -19.15% | -9.65% | +2.92% | 109B | |
| -0.92% | +4.41% | +0.43% | +3.16% | +9.04% | +36.03% | +43.69% | +12.26% | -6.40% | 106B | |
| +0.03% | -1.96% | -6.15% | -12.88% | -14.22% | -4.52% | +67.12% | +75.90% | +449.56% | 70.98B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -2.21% | +3.87% | +10.92% | +8.50% | +18.26% | +33.10% | +31.72% | +55.30% | +19.12% | 56.98B | |
| +0.87% | +3.40% | -1.32% | +25.55% | +29.07% | +69.37% | -10.11% | -5.01% | -50.42% | 53.32B | |
| +1.13% | -2.71% | +1.81% | -2.00% | -9.54% | -15.53% | +9.87% | -2.21% | +232.58% | 52.55B | |
| Average | -0.59% | +2.94% | +1.86% | +10.64% | +8.30% | +25.87% | +36.51% | +61.18% | +234.17% | 231.19B | |
| Weighted average by Cap. | -0.60% | +4.34% | +1.89% | +19.35% | +12.38% | +36.83% | +65.81% | +131.25% | +416.87% |
- Stock Market
- Stocks
- PTCT Stock
- Sector PTC Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
